Sep 2026· International Journal of Molecular Sciences· Vol 27· 0 citations· 33 references
Medicine
TL;DR
Overall, these findings support an effect of the five variants on α-galactosidase A structure and function and highlight the value of integrating clinical, genetic, biochemical, and computational data for variant interpretation.
Abstract
Fabry disease is an X-linked lysosomal storage disorder caused by pathogenic variants in the GLA gene, encoding α-galactosidase A. Enzyme deficiency leads to progressive globotriaosylceramide (Gb3) accumulation and multisystemic involvement. Here, we characterize five previously undescribed GLA variants (p.D109N, p.N215T, p.N192H, p.L166P, and p.F248S) through an integrated approach combining biomolecular and computational analyses to investigate their effects on enzyme structure, catalytic activity, and dimerization. The identified substitutions affect residues located in regions critical for protein folding and active-site integrity. The p.F248S variant may destabilize the hydrophobic core and reduce thermodynamic stability, whereas p.D109N and p.N192H may disrupt hydrogen-bond networks required for proper catalytic geometry. The p.N215T substitution is associated with impaired glycosylation, while p.L166P may induce local conformational changes that compromise correct folding. Biochemical analyses of all samples carrying these variants revealed reduced α-galactosidase A activity and increased the Gb3 levels, but also of uncertain significance (VUS). Overall, these findings support an effect of the five variants on α-galactosidase A structure and function and highlight the value of integrating clinical, genetic, biochemical, and computational data for variant interpretation. Molecular characterization of novel variants may improve genetic diagnosis, inform therapeutic decisions, and support the development of targeted treatment strategies in Fabry disease.
A systematic biochemical and structural analysis of seven genetic variants of the mitochondrial serine hydroxymethyl transferase linked to a novel brain and heart developmental syndrome is presented and the current understanding of the enzyme’s sophisticated conformational and allosteric dynamics is expanded.
Giovanna Boumis, S. Breccia, Gianluca Pistoia et al.· Frontiers in Chemical Biolog...· 1 citation
GalnsR384C and GalnsR384Y mice recapitulate key biochemical, skeletal, and histopathological features of MPS IVA and provide well-characterized murine models of severe GALNS loss-of-function resulting from clinically relevant missense variants.
Dione A Holder, B. Çelik, Sampurna Saikia et al.· Journal of Human Genetics· 0 citations
Congenital disorders of glycosylation (CDGs) are a growing group of inborn errors caused by gene defects in glycan biosynthesis pathways. Genetic testing of two patients from the same family harboring ALG1-related CDG (ALG1-CDG) revealed heterozygous variations in the c.1129 A>C and c.1263+3 A>T. Although most CDGs wit...
The patient demonstrated clinical responsiveness to sulfonylurea therapy, further supporting the diagnosis of pathogenicity, and the importance of combining clinical, genetic, and functional evidence for accurate interpretation of novel HNF1A variants is highlighted.
A structure-based computational pipeline was used to identify and evaluate inhibitors targeting the NDST1 sulfotransferase domain, and four chemically distinct small-molecule scaffolds and three peptide candidates were identified as stable binders to the NDST1 active site.
Keshav Mohan, Y. Bhargava· bioRxiv· 0 citations
Related blog posts
MIT News · Artificial Intelligence· news.mit.eduNov 9, 2026
A new machine-learning framework aims to improve the success rate of computational protein design while moving away from results that reproduce sequences found in nature.